ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	ClinicalTrials.gov
Last refreshed on:	29 July 2022
Main ID:	NCT02536755
Date of registration:	27/08/2015
Prospective Registration:	Yes
Primary sponsor:	Genzyme, a Sanofi Company
Public title:	Phase 3b Study to Evaluate Skeletal Response to Eliglustat in Adult Patients Who Completed Phase 2 or Phase 3 Studies EXOSKEL
Scientific title:	Open Label Interventional Multicenter Phase 3b Study to Evaluate Skeletal Response to Eliglustat in Adult Patients Who Successfully Completed the Phase 2 or Phase 3 Studies
Date of first enrolment:	October 27, 2015
Target sample size:	31
Recruitment status:	Completed
URL:	https://clinicaltrials.gov/show/NCT02536755
Study type:	Interventional
Study design:	Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Phase:	Phase 3

Countries of recruitment
Canada	Russian Federation	Tunisia

Contacts

Name:	Clinical Sciences & Operations
Address:
Telephone:
Email:
Affiliation:	Sanofi

Key inclusion & exclusion criteria

Health Condition(s) or Problem(s) studied

Intervention(s)

Primary Outcome(s)

Secondary Outcome(s)

Secondary ID(s)

Source(s) of Monetary Support

Secondary Sponsor(s)

Ethics review

Results

Results available:	Yes
Date Posted:	15/07/2022
Date Completed:
URL:	https://clinicaltrials.gov/ct2/show/results/NCT02536755

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.